Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Innocan Pharma Corp C.INNO

Alternate Symbol(s):  INNPF

Innocan Pharma Corporation is an Israel-based company active in the pharmaceuticals and wellness sectors. In the pharmaceuticals sector, the Company aims to provide a safe, non-opioid chronic pain management solutions for both animals and humans. To achieve this aim, the Company developed a CBD-loaded liposome drug delivery platform with exact dosing, prolonged and controlled release of... see more

CSE:INNO - Post Discussion

Innocan Pharma Corp > Private Placement of Units at a 9% Prime Above Share Price
View:
Post by Betteryear2 on Jul 25, 2023 8:46pm

Private Placement of Units at a 9% Prime Above Share Price

HERZLIYA, Israel, and CALGARY, AlbertaJuly 25, 2023 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") is pleased to announce that it intends to complete a non-brokered private placement of up to 17,220,000 units of the Company (the "Units") at a price of C$0.23 per Unit for gross proceeds up to C$3,960,600 (the "Offering"). The Offering is expected to close on or around July 20, 2023.

Innocan Pharma Announces Private Placement of Units at a 9% Prime Above Share Price (newswire.ca)
Comment by Betteryear2 on Jul 25, 2023 8:53pm
Note: There appears to be an error in release. It states: The Offering is expected to close on or around July 20, 2023. The reader should also be aware that it has not yet been posted in Sedar but the release is posted on company's website. The Company website is www.innocanpharma.com.  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities